To delve deeper into the biological functions of DBT in kidney cancer, specifically in kidney renal clear cell carcinoma (KRCC), we conducted a detailed examination of DBT's mRNA and protein levels in two renal cell carcinoma (RCC) cell lines: 786-O and A498. This evidence concerns the gene DBT and renal cell carcinoma.